Cargando…
ERO1α is a novel endogenous marker of hypoxia in human cancer cell lines
BACKGROUND: Hypoxia is an important factor that contributes to tumour aggressiveness and correlates with poor prognosis and resistance to conventional therapy. Therefore, identifying hypoxic environments within tumours is extremely useful for understanding cancer biology and developing novel therape...
Autores principales: | Takei, Norio, Yoneda, Akihiro, Kosaka, Marina, Sakai-Sawada, Kaori, Tamura, Yasuaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542132/ https://www.ncbi.nlm.nih.gov/pubmed/31142270 http://dx.doi.org/10.1186/s12885-019-5727-9 |
Ejemplares similares
-
Hypoxia-inducible ERO1α promotes cancer progression through modulation of integrin-β1 modification and signalling in HCT116 colorectal cancer cells
por: Takei, Norio, et al.
Publicado: (2017) -
Spatiotemporal Regulation of Hsp90–Ligand Complex Leads to Immune Activation
por: Tamura, Yasuaki, et al.
Publicado: (2016) -
Heat shock protein 47 confers chemoresistance on pancreatic cancer cells by interacting with calreticulin and IRE1α
por: Yoneda, Akihiro, et al.
Publicado: (2021) -
El eros
por: Bevilacqua, Alberto, 1934-
Publicado: (1995) -
SAT-LB4 Novel Hormonal and Metabolic Markers of Recovery From Overtraining Syndrome Unveiled by the Longitudinal ARM of the Eros Study - the Eros-Longitudinal Study
por: Cadegiani, Flavio, et al.
Publicado: (2020)